Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

Learn more about:
Related Clinical Trial
Severe Neutropenia After HIPEC Using Mitomycin-C Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei A Study of SGN-STNV in Advanced Solid Tumors Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis Thrombin Generation and Platelet Activation in CRS/HIPEC Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C French National Registry of Rare Peritoneal Surface Malignancies Peritoneal Surface Malignancies – Characterization, Models and Treatment Strategies Phase I Trial HIPEC With Nal-irinotecan Injection of Bromelain and Acetylcysteine in Combination Into Recurrent Mucinous Tumour or Pseudomyxoma Peritonei Results of CRS and Debulking in PMP Patients What Are the Experiences of Patients With Pseudomyxoma Peritonei? HIPEC Using High Intra-abdominal Pressure Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed Gastrointestinal Microbiome Study of Appendiceal Cancer Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

Recruitment Information


Administrative Informations